Immunotherapy Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Immunotherapy Drugs Market covers analysis - By Type (Vaccine Adjuvants, Dendritic Cell Activators & Growth Factors, T-Cell Stimulators & Growth Factors, Immune Checkpoint Inhibitors, Monoclonal Antibodies, Interleukins & Interferons, and Others), Clinical Indication (Cancer, Inflammatory Diseases, Autoimmune Diseases, Infectious Diseases, and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00003416
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

The immunotherapy drugs market is expected to grow from US$ 186.32 billion in 2021 to US$ 476.04 billion by 2028; it is expected to grow at a CAGR of 14.4% from 2022 to 2031.

Increasing demand for monoclonal antibodies has attributed to the growth of the immunotherapy drugs market. Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone and therefore consist of a single type of immunoglobulin. They are targeted toward specific antigens and bind to the antigens to form a complex. Monoclonal antibodies can be used to treat diseases such as cancer, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and cardiovascular diseases. According to the Food and Drug Administration (FDA), more than 450 monoclonal antibodies were approved till 2020. In February 2022, the FDA issued an emergency use authorization (EUA) for bebtelovimab a new monoclonal antibody that is effective against the omicron variant of SARS-CoV-2. The drug was effective in adult and pediatric patients with mild to moderate symptoms or in those who are at a high risk of progression to severe COVID-19. 

MARKET DYNAMICS
The growth of the immunotherapy drugs market is majorly attributed to increasing demand for target diseases, rising demand for biosimilars and monoclonal antibodies, and rising adoption of immunotherapy drug categories compared to traditional treatment methods. However, challenges related to manufacturing immunotherapy drugs are hampering the growth of the market. Moreover, the rising demand for personalized medicinal treatments is driving the growth of the immunotherapy drugs market during the forecast period.

Strategic Insights

MARKET SCOPE
The “Global Immunotherapy Drugs Market Analysis to 2028” report aims to provide an overview of the immunotherapy drugs market with detailed market segmentation based on type, clinical indication, and end user. The report provides key market statistics based on the performances of the leading players. It also offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global immunotherapy drugs market is segmented into type, clinical indication, and end user. Based on type, the market is segmented into vaccine adjuvants, dendritic cell activators & growth factors, T-cell stimulators & growth factors, immune checkpoint inhibitors, monoclonal antibodies, interleukins & interferons, and others. Based on indication, the market Is segmented into cancer, inflammatory diseases, autoimmune diseases, infectious diseases, and others. The end user segment is further segmented into hospitals & clinics, ambulatory surgical centers, and others.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
REGIONAL FRAMEWORK
The global immunotherapy drugs market is segmented into five major regions North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries across the world along with trends and opportunities prevailing in the region.

From the regional perspective, North America dominates the immunotherapy drugs market with ~40% market share in 2021. The market growth in the region is majorly attributed to the presence of a large number of immunotherapy drug manufacturers such as F. Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co, Novartis International AG, Johnson & Johnson, Sanofi, and GlaxoSmithKline Plc. The below figure showcase the revenue growth trend in the North America immunotherapy drugs market:

Immunotherapy Drugs Market

Source: The Insight Partners Analysis

The report analyzes factors affecting, such as drivers, restraints, opportunities, and future trends, which impact the immunotherapy drugs market. It also provides an exhaustive Porter's five forces analysis of the factors affecting the immunotherapy drugs market.

IMPACT OF COVID-19 PANDEMIC

The COVID-19 outbreak resulted in the increased demand for immunotherapy drugs, which led to a high volume of orders among drug manufacturers, resulting in a higher production volume. The rise in production volumes increased the product profit of various drug component manufacturers. Thus, the procurement of drug components grew during the initial phase of the spread of SARS-CoV-2, thereby boosting the growth of the global immunotherapy drugs market.

The majority of demand was witnessed from the vaccine adjuvant manufacturers. The US Food and Drug Administration (FDA) has granted emergency use authorization for Pfizer/BioNTech and Moderna COVID-19 vaccines. These drugs have been recommended by healthcare professionals to people 16 years of age and older, with a dose of 30 μg (0.3 m) at the cost of US$ 19.50. As a result, the procurement of drugs has increased, which will bolster the immunotherapy drugs market during the forecast period.

World Geography
Strategic Insights

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

The report covers key developments in the immunotherapy drugs market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, patents, and events. Inorganic growth strategies such as acquisitions, partnerships, and collaborations have encouraged the expansion of business and the customer base of market players. The market players operating in the immunotherapy drugs market are anticipated to experience lucrative growth opportunities in the coming years with the rising demand for immunotherapy drugs.

The report also includes the profiles of key immunotherapy drugs market companies, along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information for the last three years, and key development in the past five years. The list of a few companies engaged in the immunotherapy drugs market is mentioned below:

  • Incyte Corporation
  • Juno Therapeutics
  • Celldex Therapeutics
  • Tesaro, Inc.
  • F. Hoffmann-La Roche Ltd 
  • Amgen Inc.
  • Novartis AG
  • BioNTech SE
  • Sanofi
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Merck & Co
  • Johnson & Johnson

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Market Research

pharmaceuticals
Research Criteria
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Clinical Indication, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

The List of Companies

1. Eli Lilly and Company
2. Astrazeneca
3. Abbvie
4. Amgen inc
5. GlaxoSmithKline Plc
6. Novartis International AG
7. Merck and Co., Inc
8. F. Hoffmann-La Roche AG
9. Bristol-Myers Squibb
10. UbiVac

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Immunotherapy Drugs Market